1. Kuukasjärvi, Anna, Landoni, Juan C, Kaukonen, Jyrki, Velagapudi, Vidya, Suomalainen, Anu. 2021. IMPDH2: a new gene associated with dominant juvenile-onset dystonia-tremor disorder. In European journal of human genetics : EJHG, 29, 1833-1837. doi:10.1038/s41431-021-00939-1. https://pubmed.ncbi.nlm.nih.gov/34305140/
2. Duan, Shiyu, Huang, Wenqing, Liu, Xiaoting, Song, Wen, Zhou, Jun. 2018. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways. In Journal of experimental & clinical cancer research : CR, 37, 304. doi:10.1186/s13046-018-0980-3. https://pubmed.ncbi.nlm.nih.gov/30518405/
3. Chen, Pin-Shiuan, Wu, Meng-Chen, Tai, Chun-Hwei, Lee, Ni-Chung, Lin, Chin-Hsien. 2023. Genetic analysis of IMPDH2 gene in Taiwanese patients with isolated or combined dystonia. In Parkinsonism & related disorders, 107, 105294. doi:10.1016/j.parkreldis.2023.105294. https://pubmed.ncbi.nlm.nih.gov/36657279/
4. Zech, Michael, Jech, Robert, Boesch, Sylvia, Oexle, Konrad, Winkelmann, Juliane. . Monogenic variants in dystonia: an exome-wide sequencing study. In The Lancet. Neurology, 19, 908-918. doi:10.1016/S1474-4422(20)30312-4. https://pubmed.ncbi.nlm.nih.gov/33098801/
5. Lin, Junyu, Li, Chunyu, Cui, Yiyuan, Chen, Xueping, Shang, Huifang. 2023. Rare variants in IMPDH2 cause autosomal dominant dystonia in Chinese population. In Journal of neurology, 270, 2197-2203. doi:10.1007/s00415-023-11564-x. https://pubmed.ncbi.nlm.nih.gov/36648520/
6. Sugimoto, Atsuko, Watanabe, Takahiro, Matsuoka, Kazuhiro, Kimura, Hiroshi, Murata, Takayuki. 2023. Growth Transformation of B Cells by Epstein-Barr Virus Requires IMPDH2 Induction and Nucleolar Hypertrophy. In Microbiology spectrum, 11, e0044023. doi:10.1128/spectrum.00440-23. https://pubmed.ncbi.nlm.nih.gov/37409959/
7. Gao, Guangcan, Xue, Qingfeng, He, Jing, Zhang, Yaping, Shi, Wenyu. 2023. Single-cell RNA sequencing in double-hit lymphoma: IMPDH2 induces the progression of lymphoma by activating the PI3K/AKT/mTOR signaling pathway. In International immunopharmacology, 125, 111125. doi:10.1016/j.intimp.2023.111125. https://pubmed.ncbi.nlm.nih.gov/37907047/
8. Liu, Jiewei, Cheng, Yuqi, Li, Ming, Li, Tao, Luo, Xiong-Jian. 2022. Genome-wide Mendelian randomization identifies actionable novel drug targets for psychiatric disorders. In Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 48, 270-280. doi:10.1038/s41386-022-01456-5. https://pubmed.ncbi.nlm.nih.gov/36114287/
9. Huang, Yuting, Chan, Szehoi, Chen, Shuna, Zhang, Xingding, Zhang, Bo. 2024. Wnt/β-catenin signalling activates IMPDH2-mediated purine metabolism to facilitate oxaliplatin resistance by inhibiting caspase-dependent apoptosis in colorectal cancer. In Journal of translational medicine, 22, 133. doi:10.1186/s12967-024-04934-0. https://pubmed.ncbi.nlm.nih.gov/38310229/
10. Xu, Cheng, Wei, Zhixin, Lv, Longfei, Akimoto, Yoshie, Hu, Zhangfeng. 2024. Impdh2 deficiency suppresses osteoclastogenesis through mitochondrial oxidative phosphorylation and alleviates ovariectomy-induced osteoporosis. In Biochemical and biophysical research communications, 727, 150317. doi:10.1016/j.bbrc.2024.150317. https://pubmed.ncbi.nlm.nih.gov/38959733/